Xeris Biopharma Holdings, Inc. (LON:0A8E)

Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	783	973	378	242	135	273
Market Cap Growth	66.34%	157.58%	56.05%	79.10%	-50.46%	24.75%
Enterprise Value	893.59	1,078	511.08	356.42	190.76	262.19
PE Ratio	1902.30	-	-9.16	-5.22	-1.90	-1.89
Forward PE	47.56	64.50	-	-	-	-
PS Ratio	3.61	4.47	2.49	1.98	1.64	7.38
PB Ratio	76.99	95.32	-17.11	-47.86	4.01	3.84
P/TBV Ratio	73.51	99.06	-16.80	-47.70	3.99	2.43
P/FCF Ratio	37.73	46.72	-13.38	-6.59	-1.75	-3.79
P/OCF Ratio	36.82	45.58	-13.70	-6.90	-1.76	-3.83
EV/Sales Ratio	4.07	4.95	3.37	2.92	2.32	7.09
EV/EBITDA Ratio	26.40	39.02	-31.76	-15.08	-3.67	-3.10
EV/EBIT Ratio	47.74	58.07	-20.37	-10.86	-3.12	-3.05
EV/FCF Ratio	43.06	51.76	-18.10	-9.70	-2.47	-3.64
Debt / Equity Ratio	18.40	18.40	-8.45	-33.28	4.35	0.92
Debt / EBITDA Ratio	6.97	6.97	-12.58	-7.23	-2.84	-0.78
Debt / FCF Ratio	9.24	9.24	-7.17	-4.65	-1.91	-0.91
Net Debt / Equity Ratio	10.74	10.74	-6.75	-23.11	1.68	-0.15
Net Debt / EBITDA Ratio	3.97	3.97	-9.26	-4.95	-1.09	0.13
Net Debt / FCF Ratio	5.27	5.27	-5.28	-3.18	-0.74	0.15
Asset Turnover	0.83	0.83	0.63	0.49	0.34	0.21
Inventory Turnover	0.73	0.73	0.85	0.90	1.06	1.01
Quick Ratio	1.48	1.48	1.12	1.17	2.08	1.52
Current Ratio	2.19	2.19	1.67	1.64	2.54	1.80
Return on Equity (ROE)	-6.96%	-6.96%	301.32%	-324.20%	-134.83%	-190.28%
Return on Assets (ROA)	7.05%	7.05%	-10.01%	-12.93%	-24.88%	-49.69%
Return on Invested Capital (ROIC)	14.34%	14.34%	-17.21%	-24.28%	-58.07%	-188.24%
Return on Capital Employed (ROCE)	10.03%	10.03%	-14.95%	-17.66%	-33.03%	-64.65%
Earnings Yield	0.05%	0.00%	-10.91%	-19.15%	-52.63%	-52.90%
FCF Yield	2.65%	2.14%	-7.47%	-15.18%	-57.06%	-26.41%
Buyback Yield / Dilution	-0.87%	-0.87%	0.40%	0.13%	-16.76%	-7.46%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.